DNA Funded Review 2027 Supported Platforms and Tools

DNA Funded launched in 2024 into a market that had just watched several prop firms collapse. Its answer to the obvious question of why anyone should trust a new one was its parentage: it is backed by an Australian brokerage. This DNA Funded review for 2027 looks at what that backing means in practice, and at the challenges, platform and rules.

Background

DNA Funded began operating in 2024 and is associated with DNA Markets, a broker based in Australia. The prop firm draws on the broker's pricing, liquidity and technology relationships, and it was built from the outset around the TradeLocker platform instead of MetaTrader.

The association with a brokerage is reassuring in terms of resources and industry experience. It does not make DNA Funded a regulated product. Challenge and funded accounts are simulated, the prop firm entity is not authorised as an investment firm, and payouts are made under its own terms and conditions.

DNA Funded review of challenge types

Account sizes run from $5,000 to $200,000, with no time limit on the standard challenges. The naming is a play on the firm's brand, but the structures are the familiar ones: a one-step route for speed, a two-step route with more room, and a fast-track option with restrictions.

Fees and add-ons

Entry pricing starts at about $49 for the smallest account, which is among the lower starting prices from a broker-backed firm, and rises with account size. Fees are one-time and refundable with a payout on the main programmes.

At checkout traders can buy add-ons that change the default terms. Typical options include raising the profit split from 80% to 90%, shortening the payout cycle from fourteen days to seven, and other adjustments. These increase the price, so compare the fully configured cost with competitors' standard offers.

Profit split and payouts in 2027

The standard profit split is 80%, with 90% available through the add-on. The first payout is available after an initial period on the funded account, and the default cycle thereafter is every fourteen days, or weekly with the upgrade. Requests are generally processed within a couple of business days. Early trader reports have been positive on payment reliability, with the caveat that the firm's history is short.

Trading on TradeLocker

DNA Funded uses TradeLocker as its platform. TradeLocker is a web-based and mobile platform that grew rapidly after MetaTrader's owner restricted access for prop firms. It integrates TradingView charts, offers one-click trading and on-chart order management, and requires no download.

For traders who analyse markets on TradingView the interface will feel immediately familiar. The main limitation is for users of MetaTrader expert advisors, which cannot run on TradeLocker. Automated trading is possible through the platform's own tools and integrations, but existing MQL systems would need to be rebuilt.

Markets

One benefit of the broker connection is range. DNA Funded offers a larger set of instruments than many prop firms, covering forex pairs, indices, metals, energies, cryptocurrencies and a substantial number of share CFDs, running to several hundred markets in total. Leverage is up to 1:50 on forex on standard accounts and lower on other asset classes. Traders who want to apply their strategy to individual shares within a funded account will find more choice here than usual.

Rules

• Daily loss limit: a fixed percentage of the starting balance, calculated from the day's opening balance or equity.
• Maximum loss: static on the two-phase challenge; tighter on the one-phase and Rapid options.
• Minimum trading days: a small number per phase.
• News trading: permitted during evaluation; restricted around high-impact releases on funded accounts.
• Weekend holding: permitted on most accounts.
• Consistency: the Rapid challenge includes a rule limiting the share of profit from one day.
• Prohibited: arbitrage, exploitation of the simulated environment, hedging between accounts, and trading on behalf of others.

Scaling

Funded traders who are profitable over consecutive periods and take payouts can have their account size increased in steps, with drawdown allowances rising proportionally. As with most scaling plans, the pace is gradual and based on consistency.

Support and dashboard

The firm provides a clear trader dashboard with live tracking of objectives and limits. Support is available by live chat and email, and there is a community server for updates. Feedback from traders points to responsive service, helped by the firm's still-manageable size.

Weighing a 2024 launch

A firm that has existed for only a few years cannot show how it behaves across a full market cycle. DNA Funded's broker backing is a meaningful point in its favour, since it suggests access to capital and operational know-how. The cautious approach is the usual one: start with a smaller account, verify the payout process with an early withdrawal, and scale your commitment as the firm proves itself.

Pros and cons

Who is DNA Funded best for?

DNA Funded suits manual traders who work from TradingView-style charts, traders who want share CFDs in a funded account, and those who take comfort from a broker-backed firm. It is not the right choice for traders dependent on MetaTrader expert advisors or for those who require a long operating history.

Frequently asked questions

Risk warning: most traders who buy a challenge do not receive a payout, and the fee is not returned if you fail. This DNA Funded review is not investment advice.